The combination of radiomics analysis technology and ultrasound feature maps composed of the ultrasound feature parameters DEA, SSD, and NRD achieved 92.5% ACC in the DSNM model for PD-1 prediction in HCC patients. This evidence concerns the gene PDCD1 and hepatocellular carcinoma.